Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare, Technology, and the Agrifood-Tech sector.

TDR is a leading private equity firm with over €15 billion of assets under management and typically invests in strong European companies that are leaders in their markets. TDR has a 22-year track-record of working collaboratively with portfolio company management teams to deliver on a shared vision for growth and value creation, leveraging its investment, operational and data science expertise. TDR not only invests capital in portfolio companies, but also provides expert team resources to help bring about sustainable, positive and transformational change within its businesses.

Arsenal is a specialized private equity firm with what it believes are market-leading franchises in the healthcare and industrial sectors. Through deep immersion in our markets, we seek to discern needs and trends and craft technology- and innovation-rich strategies. Together with our management teams, we build high-growth, highly advantaged businesses that win in the market.

Over the last 20+ years we have built on our scale, focus and capabilities to become a leading investor in European and transatlantic software and services businesses. We support the building of sector-leading enterprises that supply businesses with critical software applications or workflow services, delivering a more automated workplace for their customers. This industry is characterised by digitisation trends that are in early stages of adoption and are set to transform the workplace for professionals over decades to come. Our support combines deep end-market knowledge with world class operational resources, together providing compelling support to entrepreneurial leaders looking to scale their business – businesses that are well invested, enduring and serve their customers well. With a vast European network and strong presence across North America, Hg has around 400 employees across London, Munich, New York, Paris and San Francisco, a current portfolio of over 50 businesses, worth over $150 billion aggregate enterprise value, with 115,000+ employees globally, growing consistently at +14% per year.

Founded in 2010, BEX Capital is a pioneering private equity secondaries investment firm with over $1.3 billion of assets under management. BEX is the leading buyer of limited partnership interests in fund-of-funds, secondary funds and co-investment funds. Our unique investment strategy allows us to generate exceptional returns on investments with a relatively low risk profile. We make individual investments ranging from $5 million to $1 billion. At the larger end of this scale, BEX can draw on support from its core group of investors.

Talde Private Equity is a Private Equity Investment Fund management company that invests primarily in Spanish Small and Medium Enterprises, which we support in the design and execution of their Strategic Plans focused mainly on national and international growth and sector consolidation.

Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. Vivo has approximately $5.4 billion in assets under management, invested in over 250 public and private companies worldwide. The firm is headquartered in Palo Alto, California, with additional offices in Asia. The Vivo team consists of more than 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts. Vivo provides a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.

DCM is a venture capital firm with over $4 billion under management. Since 1996, we have invested in more than 300 technology companies across the U.S. and Asia. With offices in Silicon Valley, Beijing, and Tokyo, DCM empowers our entrepreneurs with hands-on operational guidance and a global network of business and financial resources.

We have been a trusted partner for medium-sized companies and entrepreneurs since 1995. As a medium-sized investment company with many years of experience and a high level of personal commitment, we support companies in the DACH-region in their further development and growth. Through five funds, we have received over €1.0 billion in equity commitments and made over 50 investments. We are currently investing €325 million in equity from our GEP V fund.

Quilvest Capital Partners is a leading global investment firm, focused exclusively on the mid-market. As one of the earliest pioneers in the alternative investment industry, we pride ourselves on our rich and extensive history, with decades of experience deploying capital across multiple business cycles and environments. We operate four investment strategies: Primaries, Co-investments & Secondaries, Buyout, Real Estate and Private Debt. With six offices around the world, our team is well-positioned to identify the global trends and themes that underpin each of our investment strategies. We overlay this thematic approach with an extensive global network of highly valued relationships, enabling us to identify and invest in the most attractive opportunities. Our heritage dates back more than a century to 1917, managing the wealth of our founding shareholder, the Bemberg family, which we continue to do today. As the custodian of our founder’s wealth, we ensure we are fully aligned with all those across the globe who entrust us with their capital.